Squalene, min. 90%, for synthesis, 500 ml, glass packaging

5,7-Diiodo-8-hydroxyquinoline, 98.0%, 10g

N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide, 95.0%, 5g

ethyl 5-amino-1-(3-fluorophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 1g

Ethyl 3-indoleacetate, 95.0%, 5g

3,5-Dichloro-4-iodobenzoic acid, 95+%, 500mg

Citric acid monohydrate, min. 99.5%, Ph.Eur., 25 kg, plastic packaging.

(5-Methylbenzo[b]thiophen-2-yl)boronic acid, 97%, 1g

1-(4-Formylphenyl)azetidine-3-carboxylic acid, 95.0%, 1g

3,6-Dichloro-4-fluoropyridazine, 95.0%, 1g

2-(4-Chlorophenyl)-5-methyl-1,3,4-oxadiazole, 95+%, 5g

1-(3-Hydroxypropyl)-piperazine, 98.0%, 1g

(1r)-7-Chloro-1,2,3,4-tetrahydronaphthalen-1-ol, 95%, 250mg